Efficacy and safety of treatment with bulevirtide in chronic hepatitis delta: preliminary results of the real life anrs hd ep01 buledelta cohort
Fabien Zoulim,Claire Fougerou,Dominique Roulot Marullo,Sophie Metivier, Victor De Ledinghen,Vlad Ratziu, Philippe Mathurin,Veronique Loustaud-Ratti, Vincent Leroy, Jerome Dumortier,Caroline Jezequel, Didier Samuel,Nathalie Ganne Carrie, Laurent Alric,Anne Minello Franza,Armand Abergel,Georges-Philippe Pageaux,Dulce Alfaiate,Caroline Lascoux-Combe, Karine Lacombe,Isabelle Rosa,Olivier Chazouilleres,Ghassan Riachi,Xavier Causse,Julie Chas,Louis D'Alteroche,Marc Bourliere,Maria Patrizia Carrieri,Emmanuel Gordien, Massimo Levrero,Caroline Scholtes,Lawrence Serfaty,Camille Sureau,Jeremie Guedj,Alain Renault,Chloe Birkle,Estelle Le Pabic,Christelle Tual,Ventzislava Petrov-Sanchez,Helene Fontaine HEPATOLOGY（2022）
Key words
chronic hepatitis delta,bulevirtide,hd ep01 buledelta cohort,treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
